Nulode
Nulode
  • Home
  • About Us
  • Technology
  • Services
  • Reviews
  • Contact Us
  • Blog
  • FAQ
  • Our Partners
  • More
    • Home
    • About Us
    • Technology
    • Services
    • Reviews
    • Contact Us
    • Blog
    • FAQ
    • Our Partners
  • Home
  • About Us
  • Technology
  • Services
  • Reviews
  • Contact Us
  • Blog
  • FAQ
  • Our Partners

Technology Development & Commercialization

Oral Delivery Sensitive Biologics

Nucleic acid delivery - vaccines & therapeutics

Oral Delivery Sensitive Biologics

Aquaculture & Agriculture require simple delivery solutions at industry relevant pricing. NuLode is developing oral delivery methods for this market.

Protein delivery - Vaccines

Nucleic acid delivery - vaccines & therapeutics

Oral Delivery Sensitive Biologics

NuLode's Matrix Scaffold Payload (MSP) delivery technology has been used to produce subunit and bacterin vaccines for oral testing in fish. Validation still in progress

Nucleic acid delivery - vaccines & therapeutics

Nucleic acid delivery - vaccines & therapeutics

Nucleic acid delivery - vaccines & therapeutics

The MSP delivery technology has been modified to provide stability to nucleic acids (e.g., RNAi and DNA plasmids) to use in oral delivery. Research on-going.

Protein delivery - enzymes

Protein delivery - enzymes

Nucleic acid delivery - vaccines & therapeutics

The MSP technology is being tested for enzyme stabilization and release.

Product Testing

Protein delivery - enzymes

Assay development

We have worked with a number of companies to test out their products and provide supporting data for publication and/or commercial development.

Assay development

Protein delivery - enzymes

Assay development

We have developed immunoassays, bioassays and physical and chemical analysis for multiple clients to focus their product capabilities and specifications.

Copyright © 2019 Nulode LLC  - All Rights Reserved.

Powered by GoDaddy